Search clinical trials for: RUNX1-RUNX1T1

Total 30 results

Institute of Hematology & Blood Diseases Hospital...

Recruiting

Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1

AML | RUNX1-RUNX1T1 Fusion Protein Expression

China
National Cancer Institute (NCI)

Recruiting

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Inherited Bone Marrow Failure Syndrome | Familial Platelet Disorder With Predisposition to Myeloid Malignancies

United States
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML

Acute Myeloid Leukemia | Core-Binding Factor

China
Hillel Yaffe Medical Center
Weizmann Institute of Science

Unknown

Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

Israel
National Cancer Institute (NCI)

Not yet recruiting

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Lymphoma | Leukemia | Hematologic Neoplasms | Core Binding Factor Alpha Subunits

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe